Detailed Approach to Chronic Vomiting
For chronic vomiting lasting more than 2 weeks, immediately distinguish between cyclic vomiting syndrome (CVS) and gastroparesis as your primary diagnostic targets, while systematically excluding medication causes, metabolic disorders, and structural abnormalities through a structured evaluation pathway.
Initial Diagnostic Framework
Step 1: Define the Pattern and Exclude Medication Causes
First, clarify whether the patient experiences:
- Episodic vomiting (stereotypical episodes with symptom-free intervals) → suspect CVS
- Continuous symptoms (persistent daily nausea/vomiting) → suspect gastroparesis or chronic nausea vomiting syndrome
Immediately review and eliminate medications that delay gastric emptying 1:
- Opioid pain medications
- GLP-1 receptor agonists (for diabetes or weight loss)
- Anticholinergics
- Calcium channel blockers
This step is critical because medication-induced symptoms will not respond to prokinetic therapy and removing the offending agent may resolve symptoms entirely.
Step 2: Screen for Alarm Features Requiring Urgent Evaluation
Look for red flags that demand immediate investigation 2, 3:
- Severe dehydration or metabolic acidosis
- Acute abdominal pain suggesting obstruction
- Significant headache with neurologic signs
- Unintentional weight loss >5% body weight
- Age >50 with new-onset symptoms
- Hematemesis or melena
If alarm features are present, proceed directly to imaging (CT abdomen/pelvis) and upper endoscopy to exclude malignancy, obstruction, or peptic ulcer disease 4.
Step 3: Characterize the Vomiting Pattern to Guide Testing
For Episodic Vomiting (Suspect CVS)
CVS diagnostic criteria 5:
- Stereotypical episodes of acute-onset vomiting lasting <7 days
- At least 3 discrete episodes in a year, with 2 in the prior 6 months
- Episodes separated by at least 1 week of baseline health
- Absence of vomiting between episodes (mild nausea may persist)
Key supportive features 5:
- Personal or family history of migraine headaches (present in 20-30%)
- Identifiable triggers: stress (70-80% of patients), sleep deprivation, menstrual cycle, infections
- Hot water bathing behavior during episodes (48% of non-cannabis users)
- Comorbid anxiety, depression, or panic disorder (50-60%)
- Postural orthostatic tachycardia syndrome
Severity classification 5:
- Mild CVS: <4 episodes/year, each <2 days, no ED visits
- Moderate-severe CVS: ≥4 episodes/year, each >2 days, requiring ED visit or hospitalization
For suspected CVS, testing should exclude structural causes but extensive GI testing is typically unrevealing. Consider basic metabolic panel, thyroid function, and upper endoscopy if not previously done 5.
For Continuous Symptoms (Suspect Gastroparesis)
Obtain 4-hour gastric emptying study 1:
- Gold standard: scintigraphy with standardized meal (Eggbeaters or real eggs meal)
- Alternative: ¹³C-spirulina breath test
- Critical: Measure retention directly at 4 hours (not extrapolated from earlier timepoints)
- Critical: Discontinue medications affecting motility for 48-72 hours before testing (opioids, GLP-1 agonists, prokinetics)
- Optimize glycemic control in diabetics before testing
If gastroparesis is confirmed (>10% retention at 4 hours with scintigraphy), this guides specific management 1.
Step 4: Exclude Non-GI Causes
Obtain targeted testing based on clinical suspicion 3, 6:
Metabolic/Endocrine:
- Comprehensive metabolic panel (uremia, hypercalcemia, hyponatremia)
- Thyroid-stimulating hormone (hyperthyroidism, hypothyroidism)
- Morning cortisol (adrenal insufficiency)
- Pregnancy test in women of childbearing age
Neurologic:
- Brain MRI if headache pattern suggests increased intracranial pressure
- Consider vestibular testing if vertigo accompanies symptoms
Psychiatric:
- Screen for anxiety, depression, eating disorders
- Consider cannabinoid hyperemesis syndrome if cannabis use present
Step 5: Implement Targeted Management
For Confirmed Gastroparesis
Dietary modifications first 1:
- Small, frequent meals (5-6 per day)
- Low-fat diet (<40g fat/day)
- Low-residue, small-particle foods
- Liquid nutrition supplements if solids poorly tolerated
Pharmacologic therapy 1:
The AGA suggests using metoclopramide as first-line prokinetic therapy 1:
- Start 5 mg orally before meals, increase to 10 mg if tolerated
- Alternative: intranasal formulation 15 mg before meals and bedtime
- Black box warning: Risk of tardive dyskinesia (discuss with patient before starting)
- Higher risk in elderly and those on psychotropic agents
- Consider 1-4 week drug holidays every 8-12 weeks to improve tolerability
- Assess efficacy and adverse effects at 4-8 weeks
Alternative: Erythromycin 1:
- Acts as gastric prokinetic via motilin receptor agonism
- Typical dosing: 250 mg three times daily
- Tachyphylaxis may develop with chronic use
Antiemetics as needed 1:
- 5-HT₃ antagonists (ondansetron 4-8 mg)
- Dopamine D2 antagonists (prochlorperazine 5-10 mg)
- H1 antagonists (promethazine 12.5-25 mg)
- These reduce symptoms without affecting gastric emptying
For Cyclic Vomiting Syndrome
Prophylactic therapy for moderate-severe CVS 5, 7:
- Tricyclic antidepressants (amitriptyline 25-50 mg at bedtime, titrate to effect)
- Topiramate or other migraine prophylaxis agents
- Address comorbid anxiety/depression aggressively
- Treat postural orthostatic tachycardia syndrome if present
Abortive therapy during episodes 5:
- Develop individualized treatment plan for ED/acute care
- Triptans (sumatriptan) at earliest prodromal symptoms
- Aggressive IV hydration
- Antiemetics (ondansetron, promethazine)
- Benzodiazepines for anxiety component
Trigger management 5:
- Identify and eliminate/mitigate specific triggers
- Stress reduction techniques
- Regular sleep schedule
- Avoid prolonged fasting
For Chronic Nausea Without Delayed Emptying
When gastric emptying is normal but symptoms persist 6:
- Trial of serotonin antagonist (ondansetron) or dopamine antagonist (metoclopramide)
- Consider functional dyspepsia treatment (tricyclic antidepressants, mirtazapine)
- Evaluate for chronic cannabinoid use
- Psychiatric evaluation if indicated
Common Pitfalls to Avoid
Starting prokinetics without confirming delayed gastric emptying - metoclopramide carries significant risks and should not be used empirically for chronic symptoms 1
Misdiagnosing CVS as gastroparesis - CVS has episodic pattern with complete resolution between episodes; gastroparesis has continuous symptoms 5
Overlooking medication causes - always review and eliminate GLP-1 agonists and opioids before extensive testing 1
Attributing hot water bathing exclusively to cannabinoid hyperemesis - this behavior occurs in 48% of CVS patients without cannabis use 5
Failing to optimize glycemic control in diabetics - hyperglycemia itself delays gastric emptying and confounds testing 1
Not assessing treatment response at defined intervals - reassess pharmacologic interventions at 4-8 weeks to determine continuation vs. adjustment 1